子宮頸腺癌

Adenocarcinoma of the Cervix

子宮頸腺癌的比例日漸增加，有報告稱增加已達全部子宮頸癌的20％。根據文獻，早期子宮頸腺癌的治療效果，與子宮頸鱗狀上皮癌相近，但晚期的子宮頸腺癌則預後較差，可能是子宮頸腺癌對放射及化學治療的靈敏率較低。由於此種組織的子宮頸癌比例比鱗狀上皮癌少，因此適當的治療方法，須有更多的醫學中心、甚至多個國家的共同研究，才能得到更深的瞭解。

In recent years, several authors have reported an increase in the proportion of adenocarcinoma of up to 20% and more in all cervical cancer. The prognosis of patients with adenocarcinoma of the cervix is regarded as poorer than that of those with squamous cell carcinoma. In contrast to squamous cell carcinoma, adenocarcinoma of the cervix uteri is regarded as less radiosensitive. Authors reporting on the surgical therapy of the early stage of cervical carcinoma do not see any difference between the two histological types. The optimal treatment of cervical adenocarcinoma will still require a significant number of patients with contribution from multiple centers.